Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic culture-expanded bone marrow-derived mesenchymal stem cells

Mesenchymal stem cells (allogeneic, culture-expanded, bone marrow-derived) · BioCardia, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic culture-expanded bone marrow-derived mesenchymal stem cells, covering 2025-12-12 to 2025-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells [Phase 1, Phase 2]

See pricing